Show items per page
Elements: 3
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
A phase I dose-escalation study of MSC1992371A, an oral inhibitor of aurora and other kinases, in advanced hematologic malignancies Graux, Carlos; Sonet, Anne; Maertens, Johan; Duyster, Justus; ... Ottmann, Oliver G 2013
add to browser selection
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma Renner, Christoph; Zinzani, Pier Luigi; Gressin, Rémy; Klingbiel, Dirk; ... Ketterer, Nicolas 2012
add to browser selection
Long-term follow-up of patients with follicular lymphoma receiving single-agent rituximab at two different schedules in trial SAKK 35/98 Martinelli, Giovanni; Schmitz, Shu-Fang Hsu; Utiger, Urs; Cerny, Thomas; ... Ghielmini, Michele 2010